![Martina Widman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 081 $ al 31/05/2026
Martina Widman has been the Chief Operating Officer at Diamyd Medical AB since 2008.
Ms. Widman graduated from the Royal Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/08/2025 | 17.187 ( 0,01 % ) | 2 081 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DIAMYD MEDICAL AB | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
